Login / Signup
Didem Taştekin
(Didem Tastekin)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2022
Publications (10 Years): 4
Top Topics
Prognostic Factors
Neuroendocrine Tumors
Small Cell Lung Cancer
Copy Number
Top Venues
Journal of chemotherapy (Florence, Italy)
Journal of digestive diseases
Turkish journal of medical sciences
Revista da Associacao Medica Brasileira (1992)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Seval Ay
,
Muhammet Mustafa Atcı
,
Rukiye Arıkan
,
Ozgecan Dulgar
,
Deniz Tataroğlu Özyükseler
,
Nail Paksoy
,
Izzet Dogan
,
Buğra Öztosun
,
Didem Taştekin
,
Bala Başak Öven
,
Mahmut Gümüş
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.
Journal of chemotherapy (Florence, Italy)
34 (7) (2022)
Burhanettin Yalçınkaya
,
Didem Taştekin
,
Fatih Guzelbulut
,
Muslum Akgoz
,
Sadrettin Pençe
Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma.
Revista da Associacao Medica Brasileira (1992)
68 (9) (2022)
Izzet Dogan
,
Didem Taştekin
,
Senem Karabulut
,
Burak Sakar
Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.
Journal of digestive diseases
23 (8-9) (2022)
Burhanettin Yalçınkaya
,
Guzel Tanoglu Esra
,
Didem Taştekin
,
Sadrettin Pençe
Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma
Turkish journal of medical sciences
51 (2) (2021)